For citations:
Fetisova V.I., Namitokov A.M., Gilevich I.V., Kosmacheva E.D. Soluble tumorigenicity suppression protein (sST2) as a possible biomarker in patients with acute coronary syndrome. South Russian Journal of Therapeutic Practice. 2023;4(2):7-17. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-2-7-17